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Protective effects of perfluorooctylbromide emulsions
on myocardial ischemia and reperfusion (MI/R) injury were
evaluated in a modified Langendorff rat heart preparation.
Isolated rat hearts were equilibrated in Krebs-Henseleit
solution (KH) for 35 minutes and perfused with cardioplegic
solution (CPS) for 3 minutes.
Control hearts were bathed in
the CPS.
Treated hearts were given a single infusion of
100%, 50% or 25% PFOB emulsified in CPS and then bathed in
the emulsions.
All treatment groups were subjected to 3 5
minutes of ischemia.
Following reperfusion with KH
solution, hearts subjected to 100% or 50% PFOB emulsions
showed improved recovery of left ventricular function.
The
2 5% PFOB emulsion did not differ from the control.
Tissue
activities of the antioxidant enzymes glutathione
peroxidase, superoxide dismutase, and catalase were not
changed by MI/R injury in this model.
A 100% PFOB emulsion
produced no effect on these enzymes.
Levels of ATP and
reduced and oxidized glutathione (GSH and GSSG respectively)
were also determined in preischemic hearts and after
ischemia and reperfusion in both control and 100% PFOB
treated hearts.
No differences were noted in GSSG levels.
However, cardioplegia-induced MI/R injury decreased
myocardial ATP and GSH levels.
The 100% PFOB emulsion
prevented the decline in these substances.
These data suggest that PFOB emulsions protect the
myocardium against injury associated with cardioplegia and
reperfusion.
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INTRODUCTION

1.

Myocardial Ischemia and Reperfusion Injury
The heart is dependent on aerobic m etabolism for energy

production.

Ischemia occurs whe n coronary flow is

insufficient to supply the necessary oxygen for oxidatiye
phosphorylation and to remoye cellular metabolites
1970).

(Jennings

Restoration of the coronary arterial flow after a

yariable period of ischemia is called reperfusion.
Myocardial ischemia and

reperfusion

(MI/R)

injury is

produced during ischemia and exacerbated during the
reperfusion period

(Jennings et al 1985, Gettes et al 1991

and Rao et al 1983) .
Three leyels of MI/R injury are currently recognized
(Downey 1990).

The first leyel of injury produces

arrhythmias generated upon reperfusion after an ischemic
period of a few minutes

(Bernier et al 1986).

The second

leyel deyelops after 5 to 15 minutes of ischemia followed by
reperfusion and is characterized by a p rolonged decrease in
contractility.
stunning.

This state is also referred to as myocardial

Generally,

after seyeral days
et al 1986).

the heart will completely recoyer

(Bolli 1988,

Farber et al 1988, Przyklenk

The most seyere type occurs when the ischemic

period is extended to 20 minute or longer.

Some of the heart

cells will be irreyersibly injured and necrotic
al. 1990, Maxwell et al 1989).

(Groyer et

The third leyel of injury.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

2

infarction,

has attracted the greatest attention because

infarcted tissue contributes to mortality and morbidity in
the clinic.

A lot of research about M I / R has been devoted

to establishing the mechanisms involved in the development
of irreversible tissue injury.

Protective effects of

different kinds of substances have been evaluated mainly in
models of irreversible M I / R injury

(Maxwell et al 1989,

Grover et al 1990, Teoh et al 1990).
A number of different experimental models have been
employed in such evaluations.

These include:

(a) regional

or global ischemia following coronary artery occlusion or
clamping the aorta in vivo
1980, Teoh et al 1990),

(Maxwell et al 1989,

(b) total or low flow ischemia in

isolated perfused hearts or septa

(Ferrari et al 1985,

Grover et al 1990, Downey et al 1987),
experimental animals

Godin et al

(c) cardioplegia in

(Teoh et al 1990, Jones et al 1982).

Experiments have also been done in other models such as a
cardiac myocyte preparation

(Goldhaber et al 1989, Cheung et

ai 1984) .

2.

Mechanisms of MI/R iniurv
Contractile function of myocardium depends on the

hydrolysis of high energy phosphates.

The absence of

sufficient arterial flow causes a rapid lowering of
myocardial P O 2 and a loss of
198 6 ).

aerobic m etabolism

(Gettes

The maximum rate of ATP production from anaerobic
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glycolysis is less than

1 0

% of the rate of oxidative

phosphorylation necessary to sustain cardiac function
(Kobayashi et al 1979).

Insufficient substrate delivery

leads to rapid depletion of high energy phosphates.
Myocardial contraction will stop in less than one minute
after global ischemia

(Reimer et al 1986).

Excessive intracellular Ca^^ has been implicated as a
primary event in irreversible MI/R injury and cell necrosis
(Farber 19 82).

The mechanisms involved in the accumulation

are very complex.
intracellular Na+.

Depletion of ATP causes increased
The rise of intracellular Na"^ is thought

to increase intracellular Ca2+ via the Na/Ca exchange
m echanism (Reuter and Scholz 1968) .

The increased Ca^"*"

release and decreased re-uptake by the sarcoplasmic
reticulum is also thought to elevate the Ca^^ inside the
cell

(Gettes et al 1991).

The third mechanism results from

the reduced activity of sarcolemmal Ca^^ ATPase which leads
to a reduction of Ca^^ efflux and net Ca2+ uptake.
reperfusion,

During

the enhanced influx of Ca^'*’ through Ca^'*'

channels may also contribute to the large increase of
intracellular Ca^^

(Tani and Neely 1988).

In addition,

oxygen free radicals produced primarily upon reperfusion may
be involved in Ca^+ overloading.

Lipid peroxidation of

cellular structures by these free radicals can exacerbate
the above mentioned ionic perturbations

(Hearse et al 1988).

The raised cytosolic Ca^'*' in the prolonged ischemic and
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reperfused m yocardium results in an irreversible increase in
resting tension
et al 1979).

(contracture)

forming rigor complexes

(Lowe

Shortening of the myofibril associated with

contracture-rigor may be due to the loss of structural
integrity in lethally injured myocytes
Moreover,

(Ganote 1983).

the contracture-rigor may compress blood vessels

and thus restrict reperfusion capacity

(Gavin et al 1978).

The lack of venous washout secondary to the diminution
of arterial flow causes several extracellular ionic and
metabolic changes,
lactate,
1991).

such as decreased pH and accumulation of

catecholamines and lysophosphatides

(Gettes et al

Some of the alterations have been postulated to

disrupt membrane protein function and to change cellular
electrophysiology

(Corrie and Dobmeyer 1989).

Myocardial edema is another consequence of this
myocardial deterioration

(Goto et al 1991).

Edema results

from the increased intracellular concentrations of osmotic
particles such as H 2 P O 4 ", lactate and
ischemia.

produced during

Enhanced tissue osmolality leads to cellular

swelling and eventually to membrane disruption.
Oxygen-derived free radicals generated during
myocardial ischemia and reperfusion are also responsible for
MI/R injury.

These radicals are capable of various toxic

activities such as inactivation of sulfhydryl enzymes,
crosslinking of proteins,

DNA breakdown,

and lipid

peroxidation whi c h causes membrane disruption

(Freeman and
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Crapo 1982,
al 1988).

Bielski et al 1983, Brown et al 1988,

In addition,

Baker et

free radicals may cause contractile

dysfunction by inhibition of glycolysis and oxidative
phosphorylation

(Goldhaber et al 1989).

Free radicals are compounds that have unpaired
electrons in their outer shell.

This unpaired state makes

them very unstable and prone to react with other molecules
to either gain or lose electrons

(Downey 1990).

Oxygen-

derived free radicals include the superoxide anion,
radical and hydroperoxyl radical.

hydroxyl

Hydrogen peroxide,

although technically not a radical,

which

is generally included in

this list because it is the most common precursor of the
hydroxyl radical.

The hydroxyl radical is proposed to be

the most reactive of these compounds.

It has a short half-

life and usually will react within 1 to 5 molecular
diameters of its site of formation

(Pryor 1986).

The

primary reactant that serves as the ultimate source for each
of the oxidants is superoxide.

Superoxide can be easily

changed to hydrogen peroxide by superoxide dismutase

(SOD),

The hydroperoxyl radical is formed in the biological system
by protonation of superoxide

(Bielski et al 1983).

Several possible sources of oxyradicals exist:
(A), Xanthine oxidase.

Hypoxanthine release from the

ischemic heart as a consequence of increased ATP degradation
is oxidized by xanthine oxidase,
hydrogen peroxide.

generating superoxide and

An additional important feature of this

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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hypothesis is the conversion of xanthine dehydrogenase to
xanthine oxidase through proteolysis caused by ischemia
(Brown et al 1988, McCord 1985,

Chambers et al 1985).

The

enzyme is thought to exist primarily as a dehydrogenase form
in normal myocardium and does not generate free radicals.
While ischemic rat and dog hearts have abundant
xanthine oxidase,

the rabbit and human hearts contain minute

amounts of the enzyme

(Downey et al 1987,

1987, Muxfeldt and Schaper 1987).

Godin and Bhimji

This limits the

usefulness of xanthine oxidase inhibitors,
allopurinol,

such as

in MI/R injury.

(B). Dissociation of the intramitochondrial electron
transport chain,
and Boveris 1980,

also called mitochondrial " leak"
Shlafer et al 1987).

(Turrens

This is caused by

altered phospholipid integrity which inactivates cytochrome
oxidase,

resulting in release of superoxide radicals.

(C). Auto-oxidation of various substances
1985, Rao et al 1983,

Fridovich 1983, Jewett et al 1989),

such as catecholamines,
myoglobin,

(Werns et al

flavop r o t e i n s , NADH,

hemoglobin,

and reduced cytochrome c.

(D). Activation of Phospholipase A 2 by calcium influx.
This initiates production of a fatty acid,
(AA), from cell membrane phospholipids.
of AA include prostaglandins.

arachidonic acid

Major metabolites

Biosynthesis of

prostaglandins from A A can generate radicals

(Kontos et al

1985, Mathews and Holde 1990).
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(E). Leukocyte mediated free radical generation
(Lucchesi 1986 and 1990).

Leukocytes were found in

infarcted myocardium several decades ago
1939,

Fishbern et al 1978).

(Mallory et al

Recent studies have shown that

leukocytes are activated and accumulate in ischemic and
nonischemic areas

(Mullane et al 1984 Pinckard et al 1980).

After the onset of ischemia,

the initial damage of the

myocardium activates the complement system, which in turn,
promotes neutrophil activation and infiltration
al 1983).

Once activated,

(McManus et

leukocytes can release a variety

of mediators that are bacteriocidal and potentially toxic to
tissue.

Among these mediators are the free radicals.

Another important neutrophilic enzyme is myeloperoxidase.
Its reaction with H 2 O 2 can oxidize various halides,
, to produce toxic products such as HOCl
Schulz 1976).

like C l ”

(Harrison and

Other mediators released from leukocytes

include platelet-activating factor

(Lepran and Lefter 1985),

arachidonic acid, arachidonic acid metabolites and lysosomal
enzymes.
(F). Ferrous and ferric ion. Iron ions catalyze the
Fenton reaction that converts hydrogen peroxide to hydroxyl
radical;

in phosphate buffered media at neutral pH these

ferric and ferrous ions undergo cyclic oxidation-reduction
reactions which are coupled with conversion of oxygen into
superoxide

(Cohen and Sinet 1980).

Contaminant iron in the

buffer can account for this radical generation in

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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experimental models in v i t r o .

In vivo the free iron in the

blood can also undergo this auto-oxidation.

Furthermore,

free iron may be released by superoxide from iron-binding
proteins during MI/R

(Thomas et al 1985).

Although the above mentioned mechanisms involved in
free radical generation begin during ischemia,

the greatest

generation of free radicals occurs during reperfusion

(Werns

et al 1985, Downey 1990).
An additional mechanism that may contributes to MI/ R
injury is the decreased defense against free radicals in
cells following ischemic damage

(Godin et aI 1989,

et al 1985, Julicher et al 1984).

Ferrari

Free radicals are

produced by normal physiological processes.

The biosystem

has natural defense mechanisms to protect cells.
antioxidant molecules such as glutathione

Endogenous

(GSH), vitamin E,

ascorbic acid, and cysteine prevent oxidative damage
(Cotgreave et al 1988).

This defense also includes the

enzymes superoxide dismutase
glutathione peroxidase
ascorbate peroxidase,

(SOD), catalase

(CAT),

(GPD), cytochrome C peroxidase,
and GSH transferases.

SOD catalyzes a

dismutation in which two superoxides are transformed into
one H 2 O 2 and one O 2 . CAT converts H 2 O 2

to O 2

and H 2 O while

the GPD reduces H 2 O 2 to H 2 O coincident with the oxidation of
glutathione

(GSH)

and Holde 1990 pp.

to glutathione disulfide

(GSSG)

(Mathews

534-535).
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Mechanisms that contribute to M I / R injury do not work
independently.

Many interrelationships exist between them

and generally they enhance each other.
Along with the discoveries about the mechanisms
involved in the MI/R injury,

a variety of therapeutic

interventions have been developed.

A n tioxidant enzymes such

as SOD and CAT and free radical scavengers such as atocopherol were demonstrated to reduce the damage in
different experimental models
et al 1989,

(Guarnieri et al 1978,

Shlafer et al 1982).

Bolli

Exposure to endotoxin and

hyperthermic stress can induce synthesis of endogenous
tissue antioxidants and can attenuate the injury
al 1990, Currie et al 1988).

(Bensard et

Calcium antagonists have

protective effects against MI/R damage by reducing the Ca^"^
overloading

(Ferrari et al 1991).

Werns et al

(1988)

found

that inactivators of neutrophils have the ability to reduce
myocardial necrosis.

The iron chelator desferrioxamine

limits MI/R in some experimental models

(Liu et al 1990).

Enhanced oxygen delivery by perfluorocarbons during ischemia
and cardioplegia is protective in MI/R injury models

(Tomera

et al 1982).

3.

Cardioplegia
In order to expedite cardiac surgery and

transplantation,
solutions

the heart is arrested with cardioplegic

(CPS) which normally contain high potassium

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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concentrations to stop the heart in diastole.

The heart is

ischemic during the cardioplegic period and variable MI/ R
injury occurs

(Hearse et al 1981, p p . 5-6).

The earliest open-heart surgery primarily employed
moderate or profound hypothermia to reduce cardiac damage
(Bigelow et al 1950,1954; Drew and Anderson 1959).

The

severe time limitation and difficulty in maintaining
hypothermia led to the development of other methods of
myocardial protection.

In addition,

some surgeons used

cardiopulmonary bypass with a pump oxygenator,

keeping the

coronary arteries perfused and the heart beating which
obviously intensified the difficulties of the surgery

(Isom

et al 1973).
Melrose and colleagues

(1955)

introduced the concept of

"elective cardiac arrest" or cardioplegia.
the aorta,

After occluding

they rapidly injected a 2.5% solution of

potassium citrate in whole blood into the aortic root to
arrest the heart.

However,

the Melrose technique was later

abandoned because of myocardial injury associated with
potassium citrate

(McFarland et al i960).

methods such as coronary perfusion,
occlusion,

Subsequently,

intermittent aortic

topical hypothermia and ischemia at normal

temperature were employed by different groups around the
world

(Hearse et al 1981, p p . 7-12).
The need to protect the m y o c a r d i u m and at the same time

to maintain a clear operating field for surgery preserved

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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interest in cardioplegia.

This led to a better

understanding of the factors which are necessary to safely
induce chemical arrest
function.

while preserving cell structure and

Actually the reported effects of potassium

citrate may have been due to tissue ischemia.

Gay and Ebert

(1973), Holscher

suggested

(1967)

and Tyers et al

(1975)

that the high concentrations of potassium and citrate were
responsible for much of the damage.

CPS of the 1 9 6 0 's and

1970's contained components which differed from the initial
formula

(2.5% potassium citrate)

other.

Hearse

(1974,

and also differed from each

1975 and 1976)

tested experimentally

the individual components of these solutions on the isolated
rat heart in the Rayne Institute at St Thomas*
London.

Hospital in

He advocated that CPS should retain as closely as

possible extracellular,
concentrations of ions.

rather than intracellular,
He also recommended that additions

which were individually effective would be used only in
their optimal concentrations.

The "St Thomas Solution" he

proposed based on this principle contained physiological
concentrations of sodium and calcium to which were added 16
mmoles/L KCl to arrest the heart instantly,

16mmoles/L MgCl

which had been shown to have a marked additive effect to the
potassium for myocardial protection,
hydrochloride.

and 1 mmole/L procaine

This is the formula of the St. Thomas'

Hospital Cardioplegia Solution N o . 1 which was used
continuously between 1975 and 1981

(Hearse et al 1981,
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p p . 12-14).

Worldwide clinical experiences with this or

other very similar solutions indicated that they induced
cardiac arrest rapidly and,
hypothermia,

in combination with topical

afforded excellent myocardial preservation

(Braimbridge et al 1977,
Tyers et al 1977).

Conti et al 1978,

Cooley 1979,

In 1981, this formulation was modified

to include buffering and pH control with a small reduction
in sodium and calcium

(Hearse et al 1981, p p . 159).

This

modified solution is now called St. Thomas* Hospital
Cardioplegia Solution N o . 2 and is the most widely used CPS
in the United States and Europe

(Ledingham et al 1990).

The overall protection afforded by cold chemical
cardioplegia is contributed by three important components:
energy conservation through the rapid chemical induction of
cardiac arrest,

the slowing of metabolism and degenerative

processes by hypothermia,

and the prevention of unfavorable

cellular changes by the inclusion of specific protective
agents in the cardioplegic solution

(Hearse et al 1981,

p p . 151).
Chemical induction of cardiac arrest is most commonly
produced by mild hyperkalemia

(Melrose et al 1955).

its optimal concentration range

Within

(between 10 and 3 0 m e q / L ) ,

potassium very effectively arrests the heart in diastole
with few side effects on tissue
1979).

(Tyers et al 1977, Buckberg

Substantial depletion of calcium and sodium can also

induce cardiac arrest

(Gebhard et al 1983).

However,
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also produce harmful effects on the cells
1978,

Sachror et al 1979, Jynge 1980b)

(Gordon et al

and it would appear

simpler to produce cardioplegia with solutions like the one
proposed by Hearse

(197 6 ).

The second component is hypothermia caused by local
cooling.

Numerous experimental studies have shown that

hypothermia and chemical cardioplegia complement each other
and together ensure additive tissue protection
1980, Jynge 1980a,

Preusse et al

(Hearse et al

1979) .

When the optimally formulated CPS is used during
cardioplegia, myocardial deterioration is primarily due to
MI/R injury.

With greater understanding about the

mechanisms involved in the MI/R damage,

it should be

possible to prevent or at least delay some of these critical
changes using carefully designed interventions.

Several

protective interventions have been incorporated
experimentally and/or clinically in cardioplegic procedures.
These possibilities include the following;

(a) Adding

glucose and insulin or intermediates plus alternate
substrates of oxidative metabolism to stimulate the
anaerobic energy production
1990, Rousou et al 1986).
phosphate

(Lolley et al 1974, Teoh et al
(b) Supplying of ATP and creatine

(Hearse et al 1976).

(c) Buffering with

bicarbonate to combat acidosis of anaerobic glycolysis
during ischemia

(Jynge et al 1981, Buckberg 1979).

Experimental evidence suggests that the optimum pH during

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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cardioplegia is alkaline

(7.9-8.1).

(d) P roviding mannitol

or other agents to counter cell swelling

(Goto et al 1991).

(e) Including ion channel blockers such as the calcium
channel blockers, verapamil and nifedipine
et al 1978,
al 1979).
procaine

Clark et al 1977),

and beta blockers

(Magee et

(f) Adding several anaesthetic agents such as
(Kay et al 1978).

electromechanical arrest,
cell membranes.
CPS

(Rodd-Nicholson

In addition to inducing
procaine is thought to stabilize

(g) Inclusion of free radical scavengers in

(Bando et al 1988).

(h) Inclusion of oxygen to main t a i n

aerobic energy production.

At the present time both

oxygenated crystalloid CPS and blood have been used
clinically to minimize the oxygen debt arising during
ischemic arrest

(Bleese et al 1978, Buckberg 1979).

The

blood cardioplegic technique uses the blood as a vehicle of
cardioplegic agents and oxygen.

In 1978,

Follette et al

reported their findings on blood cardioplegia in animals and
humans.

They showed that mix i n g cool cardioplegic solution

with autologous blood allowed prolonged aortic clamping to
be accomplished in the animal experiments and resulted in
postoperative recovery in patients compared with unmodified
blood.

Other groups compared the blood cardioplegia wit h

crystalloid cardioplegia in laboratory experiments and
clinical trials
Fremes 1984).

(Engelman et al 1980,

Feindel et al 1984,

Blood cardioplegia provided better myoca r d i a l

protection than did crystalloid cardioplegia.

As a kin d of
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oxygen carrying vehicle,

perfluorocarbons have been employed

as cardioplegic adjuvants and have improved recovery of
cardiac function

(Flaherty et al 1984, Rousou e t _a_l 1982,

Hicks et al 1983, Ranter 1981).
solubility at low temperature
After Magovern et al

(1982)

PFCs have increased oxygen

(Naito and Yokoyama 1978).

indicated that blood failed to

deliver significant amounts of oxygen to protect myocardium
at lower temperatures,

perfluorocompounds as a means of

oxygenating crystalloid cardioplegic solutions became more
appealing.

Novick et al

effect of crystalloid,

(1985)

compared the protective

blood and Fluosol-DA cardioplegia on

hypertrophied pig myocardium.

They concluded that Fluosol-

DA cardioplegia was the most effective.

4.

Perfluorocarbons
Perfluorocarbons

carbon and fluorine.
nitrogen,

(PFCs)

They may contain other atoms such as

oxygen and bromide

are chemically inert,

are predominantly comprised of

(Yokoyama et al 1983).

insoluble in other materials and

resistant to thermal and radiation damage.
solvents for gases.

They are good

Approximately 40 ml of oxygen can

dissolve in 100 ml of most PFCs and C O 2
soluble as oxygen

PFCs

is at least twice as

(Sargent and Seffle 1970).

These

properties of PFCs make them potentially useful for a
v a r i e t y of biological purposes,

such as gas transport.

well-k n o w n application is as a blood substitute.

One

PFCs may
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be gases,

liquids or solids.

preparations,
hydrophobic,

For use in blood substitute

liquid PFCs are preferred.

Because they are

it is necessary to emulsify t h e m for

intravenous use and organ perfusion.

Presently,

the most

extensively used emulsifying agents are Pluronic F 6 8
various phospholipids

(Geyer 1988) .

and

Emulsions which are

used as blood substitutes must have a suitable vapor
pressure and short retention time in tissue.

Only a small

number of PFCs are currently viable candidates for
biological use and most have been proven unsatisfactory
(Geyer 1988).

PFCs exert no osmotic or oncotic pressure.

Electrolytes or plasma volume expanders mu s t be added to
circumvent this deficiency
The solubility of O 2

(Alexander et al 1975).
and C O 2

in liquid PFCs makes them

well suited to carry oxygen from the lungs to other tissues
and to transport C O 2
al 1969) .

from tissues to the lungs

(Sloviter et

Animal research with PFCs as blood substitutes

has produced good results

(Geyer 1975)

and their initial

clinical application has been successful
and Yang 1988) .

(Mitsuno 1988, Chen

Bloodless animals perfused with PFC

emulsion survive and rapidly produce new plasma proteins and
red cells

(McCoy 1988).

Geyer

(1975)

also demonstrated that

rats, perfused with PFC, tolerated toxic levels of carbon
monoxide.

In contrast to red blood cell,

simultaneously carry oxygen,
dioxide.

PFCs can

carbon mono x i d e and carbon

The oxygen solubility of PFCs is not affected by
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carbon monoxide.
Although PFCs are inert compounds and usually nontoxic,
they can produce some side effects wh e n administered
intravenously for a fairly long period of time.

The major

adverse effects relate to excessive deposition in the liver
and spleen.

Anaphylactoid reactions,

complement activation,

hypotension,

changes in the immune system,
et al 1973,

leukopenia,

and other

have also been observed

Caiazza et al 1988,

Hollands 1988) .

whi c h include

(Clark

Zhang et al 1988, Lowe and

Some perfluorinated compounds are

peroxisome proliferators and act as a positive modulator of
hepatocarcinogenesis.

Abdellatif et al

(1991)

determined

that perfluorooctanic acid can significantly increase the
incidence of hepatocellular carcinoma in response to
carcinogenic agents.
PFC emulsions have been successfully used to preserve
organs such as kidney,

liver and heart for transplantation

(Fuchinoue et al 1985,

Baba et al 1988,

Biro et al 1989,

Tomera and Geyer 19 82).
Another important application of PFCs is as an
oxygenating agent.
have excellent

0 2

Not only do the PFC containing products

-carrying capacity,

they also release O 2

at

a higher partial pressur e than would occur with a plasma/red
blood cell mixture.

Since PFC particles are approximately

1/70 the size of red blood cells,

they can penetrate past

partial vascular obstructions into areas that are
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inaccessible to red blood cells.
unload O 2

PFC particles load and

faster than do erythrocytes.

The lower viscosity

of PFC emulsions facilitates a hig h er flow into tissues.
(Fischer et al 1986,

Geyer,

1975).

Hypoxia limits tumor radiotherapeutic efficacy because
oxygen is a potent radiosensitizer.
radiotherapeutic levels,

At usual

only a small amount of damage can

be produced by direct interactions between radiations such
as X-ray or gamma rays and biological molecules.

Most

critical damage is produced indirectly by a variety of
radicals and other chemically reactive species which are
generated through chemical reactions in the tissue initiated
by radiation.

Oxygen participates in these chemical

reactions leading to radiation damage.

Solid tumors have a

poor blood supply and consequently contain insufficient
oxygen tension to allow efficient radiotherapy
1988).

(Rockwell

The beneficial rheological characteristics of PFC

emulsions

(i.e.

small particle size and low viscosity)

allow

them to increase tumor oxygenation and improve radiotherapy
(Teicher and Rose 1984).
PFC emulsions have also been used to treat brain
ischemia.
hypoxia,

Because the brian is so rapidly affected by
it is crucial to r eplenish the supply of O 2 as

rapidly as possible.

Both experimental and clinical studies

have demonst r at ed the efficacy of these blood substitutes in
brain ischemic tissue

(Clark et al 1989,

Chen et al 1988) .
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MI/R injury is initiated by insufficient oxygen
supply.

PFCs which possess effective oxygen carrying ability

and therefore can delay hypoxia have been obvious candidates
to rescue ischemic hearts.

Glogar et al

(1981)

demonstrated

that PFC preparations markedly reduced the infarcted area in
a regionally ischemic canine heart model when they partially
replaced the blood and the animals breathed
Rude et al

(1982)

1 0 0

% oxygen.

indicated that PFC emulsions improved

oxygen supply to the myocardium in a similar regional
ischemic model.
ischemic model,

Based on the isolated rabbit heart global
Parrish et al

(1984)

argued that the

benefits shown by PFCs when us ed during reperfusion could be
attributed to their superior rheological properties.

The

special rheological characteristics of PFCs may also be one
of the mechanisms by which they limit ischemic damage when
used during occlusion episodes
(1989)

(Glogar 1981).

Bajaj et al

demonstrated that myocardial preservation by PFCs was

associated wi th their ability to suppress the enhanced
neutrophil margination and infiltration into myocardium
caused by ischemia.

Oxygenated perfluorochemical

cardioplegic solutions can support aerobic metabolism and
therefore delay depletion of h igh-energy phosphate during
cardiac arrest

(Rousou et al 1982,

Bando et al 1988).

Flaherty et al 1984,

Inclusion of PFCs in cardioplegic

solution p revented intracellular acidosis and the
accumulation of lactate,

creatine phosphokinase and
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thiobarbituric acid reactive substances
peroxidation)

(products of lipid

in the coronary effluent.

One of the most serious deficiencies of PFC blood
substitutes is their limited oxygen carrying capacity,
related to their low PFC content
instance,

(Arlen et al 1988).

the first commercial preparation,

contains only 20%
fluorochemicals,

(w/v).

For

Fluosol-DA,

One of the b rominated

perfluorooctylbromide

(PFO B) , was first

synthesized as a nontoxic contrast agent for fluoroscopy,
NMR imaging and ultrasonography.

PFOB has the capability to

form reasonably stable emulsions at higher concentrations
than most other PFCs

(Long et al 1988).

A 100%

(w/v)

emulsion, which is easy to achieve, has m o r e than four times
the oxygen-carrying capacity of Fluosol-DA

(a 20% PFC

emulsion)

tested the

(Riess 1988).

Biro et al

(1989)

cardioprotective effects of this novel PFC emulsion
w/w)

(50%

on a modified Langendorff rat heart preparation.

They

found that after switching the perfusate from aqueous
perfusate to PFOB emulsion,

contractile perfor m an ce of

hearts was significantly higher.

However,

protective

effects of this PFC emulsion have not been determined in
M I/ R injury models.

5.

Tationale for These Experiments
A 100% PFOB emulsion has a very high oxygen-carrying

capacity.

M I / R injury occurs during cardiop le gi c processes.
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This damage is initiated by hypoxia.

The hypothesis that

oxygenated PFOB-containing cardioplegic solutions can
prevent the decline in cardiac function associ a te d with
cardioplegia was tested in the modified Langendorff rat
heart preparation.
Several mechanisms of successful interventions in MI/ R
injury exist.

They include prevention of the depletion of

ATP and endogenous free radical scavengers such as
glutathione

(GSH).

Also,

endogenous antioxidant enzymes

such as superoxide dismutase
glutathione peroxidase

(SOD), catalase

(CAT), and

(GPD)) can be m ai nt ai ne d or induced.

The ability of PFOB to preserve endogenous antioxidant
defenses and ATP levels during crystalloid cardioplegia was
also determined in these experiments.
Although cold cardioplegia is commonly performed in
clinical surgery,

hypothermia is still controversial

(Lessana et al 1992) .

Hypothermia is an alternative way to

protect the myocardium by slowing metabo li sm and
degenerative processes.

The aim of the current study was to

define the cardioprotective effects of PFOB emulsions.
Application of hypothermia in this research would make the
result more difficult to interpret since there would be
another protective factor to consider.
this research,
temperature

In order to simplify

all investigation was u n de rt ak en at normal

(37°C).
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MATERIALS AND METHODS

ANIMALS A N D HOUSING:
M ale Sprague-Dawley rats, weighing 400-500g, were used.
Two rats wer e housed together in a wire- m es h cage over woodchip bedding.

Purina lab chow and wat e r wer e available ad

lib during 12 hour light-dark cycles.
allowed a minimum of

2

All animals were

days acclimatization before use in

the experiments.

REAGENTS AND DRUGS:
Drugs and reagents were obtained from the indicated
sources.
sulphate

Sodium pyruvate,

T etrabutylammonium hydrogen

(TBAHS),

Ethylenediaminetetraacetic acid
form,

Glutathione reductase,

n i n u c l e o t i d e , reduced form
dinucleotide phosphate,
acid,

Triethanolamine,

(EDTA), Glutathione,

reduced

B-Nicotinamide adenine

(NADH), B- Ni co ti na m id e adenine

reduced form

(NADPH), Sulfosalicylic

Diethylenetriamine-pentacetic acid

(DTPA), 2,4-Dinitrophenylhydrazine,

Pyrogallol,

(Sigma Chemical Co.

P otassium chloride

St Louis, M o ) .

(KCl), Sodium bicarbonate
Sodium phosphate monobasic
dibasic

(K2 H P O 4 ) ,

Acetonitrile,

Triton X-100

(NaHCOg), Calcium chloride

(CaCl),

(KH 2 P O 4 ) , P ot as si um phosphate

Sodium hydroxide

(NaOH), Tris

(Baker Chemical Co. Phillisburg,

P otassium phosphate monobasic

(buffer),

NJ).

(KH2 P O 4 ) , P e rc hl o ri c Acid,

22
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Hydr og en perox id e
Chemical.

Fair Lawn, N J ) .

M ag ne si um sulfate
Science,

(H2 O 2 ) , Hydrochloric acid
Sodium chloride

New York,

NJ).

(H2 SO 4 ) , (EM

Pota s si um permanganate

(Mallinckrodt Chemical W o r k s , St Louis,
(MgCl 2 '6 H 2 O)

(Fisher

(NaCl),

(MgSO^'7 H 2 O ) , Sulfuric acid

Cherry Hill, N J ) . Dextrose,

chloride

(HCl)

Mo).

M agnesium

(Allied Chemical & Dye Corporation,

5,5 '-Dithiobis(2-nitrobenzoic acid

(ICN Biochemicals,
Chemical Company,

Cleveland,

OH) .

2-Vinylpyridine

Inc. Milwaukee, W I S ) .

Wyandotte Corporation,
Perfluorooctylbromide

(DTNB)
(Aldrich

Pluronic F 6 8

(BASF

Wyandotte, M i c h i g a n ) .
(PFOB)

(PCR Incorporated,

Gainesville,

Florida).

EXPERIMENTAL PROTOCOL:
1. Cardioplegic reperfusion injury:
Male Sprague-Dawley rats, weighing 400-500g,
anesthetized with sodium p e n t o b a r b i t a l ( 1 0 0

were

mg/Kg i .p .),

intubated to maintain ventilation during cardiac procedures,
and heparinized.
inserted.

Hearts were perfused wi t h modi fi ed Krebs-Henseleit

(KH) solution
KH2 PO4

The aorta was isolated and a cannula

(NaCl 112 mM; KCl 5 mM; M g S O ^ "7 H 2 O 1.2 mM;

1 mM; N a H C O ]

25 mM; Dextrose 11.5 mM; Na Pyruvate 2 mM;
m M ) , aerated with 95%

0 2

CaCl-2 H 2 0

- 5 % C O 2 gas mixture,

of 80 m m H g and a temperature of 3 7 ° C .

1.2 5

at a pressure

Hearts were suspended

in a heated muscle bath filled with KH solution.

The left
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atrium was removed to allow the insertion of a balloon
cannula into the left ventricle.

The balloon cannula was

connected to a pressure transducer to monitor heart rate and
left v entricular developed
pressure

(LVDP).

Hearts were allowed to equilibrate for 15 minutes
before the balloon was inflated to 5 mm H g LVDP. After 2 0
minutes,

coronary flow

recorded.

(CF), heart rate

(HR), and LVDP were

A one-ml sample of perfusate was obtained for

determination of lactate dehydrogenase

(LDH)

was determined with a kit supplied by Sigma
N o . 500)

as described in Appendix A.

expressed as Berger-Broida
estimated as double product
LVDP / l O O O ) .

activity.

LDH

(Procedure

LDH release is

(B-B) units/ml.

Cardiac function

(DP) was calculated as

(HR x

Hearts were switched to another reservoir

which contained the St. Thomas' Hospital Cardioplegic
Solution N o . 2 (CPS)
CaC l 2 '2 H 2 0

(NaCl llOmM; KCl 16mM; M g C l 2 *6 H 2 0

1.2mM; NaHCO] l O m M ) , aerated with 95%

gas mixture.

After perfusion for 3 minutes,

0 2

16mM;

-5 % CO2

the flow of CPS

was shut off and the KH in the bath was replaced by the same
cardioplegic solution.

After a 30 minute global ischemia,

the hearts were reperfused by KH and the CPS in the bath was
replaced with KH.
reperfusion,

Following a 3 0-minute period of

values for HR, LVDP,

CF,

DP and LDH activity

were determined again.
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2. PFOB emulsions:
Emulsification of PFOB was accomplished by adding the
appropriate we ig h t of the compound to the appropriate volume
of CPS containing 2.7% Pluronic F - 6

8

, a surfactant.

The

mixtures wer e sonicated with a Branson Sonifier resulting in
a cloudy,
with 95%

but stable,
0 2

-5 % CO2

emulsion.

The emulsions were aerated

for 15 minutes before use.

Hearts

exposed to PFOB were treated the same as control hearts,
except that they were subjected to a single infusion of PFOB
emulsion to fill the coronary circulation and then immersed
in the PFOB emulsion.

Values for HR, LVDP,

activity were again determined prior

CF, DP and LDH

to cardioplegia and

after 30 minutes of reperfusion.
3. Tissue preparation:
At the end of the 3 0 minute reperfusion period,

left

ventricular tissue was rapidly frozen and stored in liquid
nitrogen.

Less than 1 week later ATP and intracellular

antioxidant assays were performed with the wet tissue.

A

control group of hearts were frozen just prior to ischemia
for determination of pr eischemic values.

Contents of the

substances and activity of enzymes were expressed per gram
of wet tissue weight.
4. Assays:
The detailed procedures for intracellular substance
assays are descri be d in the Appe nd ix A.
a. ATP was m e a s u r e d by counter ion HPLC

as modified
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method of Sellevold et al

(1986).

tissue wit h 0.42M perch lo ri c acid.

ATP was extracted from
The perch lo ri c acid was

then n eutralized w i t h 1.0 M KOH in the presence of an
indicator,

0.1% chlorphenol red.

column was used.
acetonitrile

A C-18 reverse phase

The mob il e phase was a degassed 10%

: 9 0% K H 2 P O 4 mixture.

ATP standard solutions

were used to establish the standard curve for quantifying
the ATP level in tissue.
b. Glutathione

(GSH)

and crlutathione disulfide

fGSSG^ were

determined enzymatically by the DTNB-GSSG reductase
recycling
procedure

(Anderson,

1985).

The samples were deproteinized

by treatment w i t h 5% 5-sulfosalicylic acid. GSH was oxidized
by 5,5'-dithiobis(2-nitrobenzoic acid)

(DTNB)

to GSSG with

stoichiometric formation of 5-thio- 2 -nitrobenzoic acid
(TNB). GSSG was rapidly reduced by GSSG reductase and NADPH
which were added in the reaction mixture.

The rate of TNB

formation was followed at 412 nm and was proportional to the
sum of GSH and GSSG present.

GSSG was measured by masking

GSH with 2-vinylpyridine before running the assay.

GSH was

then calculated by subtracting the GSSG from the total
glutathione.
c. Glutathione peroxi d as e

(GPD) was determined by continuous

monitoring of GSS G formation in the reaction mixture
and Gunzler 1984).

(Flohe

GSH is oxidized by GPD to GSSG. The GSSG

is then reduced by an excess of glutathione reductase to
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maintain a constant level of GSH.

The rate of concomitant

oxidation of NA D P H is proportional to GPD activity and can
be monitored s p e c t r o p h o t o m e t r i c a l l y .
d. The total amount of suoeroxide dismutase

CSOD) was

assayed by the pyroga ll ol auto-oxidation meth o d
McDonald 1985).

(Maestro and

This assay is based on the ability of SOD

to scavenge super ox id e anion radicals.

Removal of these

molecules decreases the overall rate of pyrogallol
autoxidation.

The tissue samples were homogenized in 10 mM

potassium phosp ha te buffer supplemented with 3 0 mM KCL.
e. Catalase

CCAT)

used for SOD.

samples were prepared in the same buffer

Prior to the determination,

ethanol and

Triton X-100 were added into the sample to increase the
observable catalase level by decomposing the inactive
complex of catalase with H 2 O 2
enzyme.

or directly activating the

Samples w e r e added to a standardized amount of H 2 O 2

solution.

The H 2 O 2 whic h remained in the reaction mixture

after 3 minutes was titrated with potassium permanganate.
The catalase activity was inversely proportional to the
amount of H 2 O 2

left in the reaction mixture

(Cohen et al

1970).
5. Statistics;
ANOVA and Newman -K eu l s procedures were employed to
determine signi fi c an t differences among multiple treatment
means

(Steel and Tor ri e 1960).

(p < 0.05 = significant

difference)
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RESULTS
Preliminary studies showed that a three minute coronary
perfusion with CPS stopped all hearts.

The following 3 5

minutes of ischemia and an additional 3 0 minutes of
reperfusion with KH produced significant decreases in left
ventricular contractile function
and coronary flow.

A significant increase in extracellular

LDH accumulation also occurred.
heart rate were noted.
Pluronic F - 6 8

(LVDP and Double Product)

No significant changes in

The surfactant control

in CPS) produced similar results

(2.7%
(Figs.

1-5).

We also observed that the ischemic time was very critical
since 3 0 and 3 8 minutes of ischemia produced minimal and
maximal injury, respectively.
Statistical analysis indicated no significant betweengroup differences for preischemic ventricular contractile,
coronary flow values and extracellular LDH levels.

Both

100% and 50% PFOB emulsions prevented the decline in left
ventricular contractile function
in control treatments.
this protection

(Figs.

(LVDP, Double product)

seen

The 25% PFOB did not demonstrate
2 and 3).

However,

the decrease in

coronary flow associated with reperfusion injury was not
affected by any of the PFOB emulsions

(Fig. 4).

Heart rate

was not altered by the PFOB emulsions

(Fig.

The

1).

elevation in extracellular LDH was not significantly reduced
by the 100% PFOB emulsion even though contractile function
was sustained by this high concentration of the

28
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emulsion

(Fig. 5).

ATP, glutathione and endogenous antioxidant enzymes
were only investigated in control and 100% PFOB treated
hearts.

Cardioplegia-induced ischemia and reperfusion

reduced the tissue ATP concentration.
able to maintain a normal ATP level.

The 100% PFOB was
There is no

significant difference in ATP content between preischemic
tissue and postischemic tissue treated with 100% PFOB
(Fig.

6

).

Table 1 shows that cardioplegia followed by reperfusion
depleted the total glutathione and GSH levels in the
myocardium, while the GSSG was not significantly decreased.
The 100% PFOB prevented the loss of the total glutathione
pool inside the cells.

However,

while there was no

significant difference in GSH values between the preischemia
control and the 100% PFOB treated group,

the latter had less

total glutathione content than the preischemic hearts.
The myocardial antioxidant enzymes GPD,

CAT,

and SOD

were not significantly altered by the cardioplegia-induced
MI/R injury.

The 100% PFOB failed to modify any of these

intracellular antioxidant defenses

(Table 2).
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EFF E C T OF PFOB O N H E A R T RATE
P r« Ischemia

P oatIschemia

350
300
m

H
3
Z

i
cc
UJ
o.

(/)
H

<

250
200 r
150

100

UJ
00
50 r

Control

Fig. 1.

Pluronic
F -68

100%PFOB

Pre-Ischemia = preischemic value.

50%PFOB

25%PFOB

Post-Ischemia =

value after 35 minutes of ischemia and following 30 minutes
of reperfusion.

PFOB = perfluorooctylbromide emulsions in

cardioplegic solution administered during time of ischemia.
Pluronic F-68 represents a control containing 2.7% of this
surfactant. Bars represent mean ± SEM.

Number of rats used

is given above the bars.
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E FF E C T OF PFOB ON L EFT V E N T R IC U L A I
DEVELOPED PRESSURE
P re Ischemia

Post”
Ischemia

15 0

120

O)
X

E
E

-

90

60

30

Control
Fig. 2.

Pluronic
F -6 8

100%PFOB

50%PFOB

25%PFOB

Terms are the same as for Fig. l.

* = significantly different from its respective preischemia
value.

** = significantly different from its respective

preischemia value and from the control value,

(p < .05 =

significant difference).
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EFFEC T OF PFOB ON DOUBLE PRODUCT
P re Ischemia

É P ostIschemia

40

H
O
3

30 -

a

o

tc

Cl

20

U

§O
a

10

-

Control

Pluronic
F -6 8

100%PFOB

50%PFOB

25%PF0B

Fig. 3. Terms and marks are the same as for Fig.1 and Fig.2.
Double product = (heart rate x left ventricular developed
pressure)/lOOO.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

33

E F F E C T OF PFOB O N C O R O N A R Y FLOW
P re Ischemia

P ostIschemia

25

UJ
H
3
Z
fiC
UJ
Û.

20

-

15

10

5 -

Control

Pluronic
F -6 8

100%PFOB

50%PFOB

25%PFOB

Fig. 4. Terms and marks are the same as for Fig.1 and Fig.2.
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E FF E C T OF PFOB O N LD H A C TIV ITY
P re Ischemia

Post —
Ischemia

900

CO

180

Control

100%PFOB

Fig. 5. Terms and marks are the same as for Fig.l and Fig.2.
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EFFECT

O F P FO B

ON A T P LE V E LS

IN H E A R T
P r e - Is c

#

TISSUE

P o s t - is c
c ontrol

P o s t - is c .

lOO%PFOB

800

N=13
(D 600

N=8

N=5

Fig. 6.

Pre-Isc = preischemic value.

Post-isc control =

control value after 3 5 minutes of ischemia and following 30
minutes of reperfusion.

Post-isc 100% PFOB = value after

ischemia and reperfusion with administration of 100% PFOB
emulsion in cardioplegic solution

during ischemia.

Bars

and sample size are given in the same way as for Fig. 1.

*

= significantly different from all other values (p < .05) .
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Table 1. Effects of PFOB on Glutathione Levels in Heart
Tissue

GSH
(umol/g tissue)
GSSG
(umol/g tissue)
GSSG + GSH
(umol/g tissue)

Pre-Ischemia

Post-Ischemia

Post-Ischemia

Control

Control

100% PFOB

1.44 ± 0.060

0.79 ± 0.0803

1.22

(n =

1 1

)

0.23 ± 0.012
(n =

1 1

)

1.57 ± 0.050
(n =

1 1

)

(n =

6

)

0.19 ± 0.009
(n =

6

6

0

.0 7 b

(n =

6

)

0.19 ± 0.016

)

0.95 ± 0.0723
(n =

±

)

(n =

6

)

1.41 ± 0.05?3,b
(n =

6

)

All values are Mean ± SEM.

^ Significantly different from preischemic value,

b Significantly different from postischemia control value.
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Table 2. Effects of PFOB on the Activity of Myocardial
Antioxidant Enzymes
Pre-Ischemia

Post-Ischemia

Post-Ischemia

Control

Control

100% PFOB

20.38 ± 0.65

17.73 ± 0.87

18.84 ± 1.52

(n = 8 )

(n = 6)

(n = 6)

2.95 ± 0.15

2.37 ± 0.24

2.83 ± 0.09

(n = 6)

(n = 6)

(n = 6)

257.9 ± 25.1

252.8 ±17.4

241.7 ± 26.0

(n = 6)

(n = 6)

(n = 6)

GPD
(umol NADPH
oxid/min/g tissue)
CAT
(k X 10 ”2)

SOD
(units/g tissue)

GPD = Glutathione peroxidase, CAT = Catalase, SOD =
Superoxide dismutase.
All values are Mean ± SEM.
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DISCUSSION
The control data indicated that this cardioplegic model
caused reproducible and measurable MI / R injury simulating
that induced by hypothermic cardioplegia.
(1982)

Shlafer et al

tested cardioprotective effects of several solutions

a dministered during ischemia in an isolated rabbit heart
preparation.

They demonstrated that following a 2 hour

hypothermic cardioplegia

(27°C)

and a 1 hour reperfusion

with oxygenated physiological saline solution, hearts
incurred significant decreases in LVDP,

left ventricular

compliance,

the maximum rate of left ventricular pressure

development

(dP/dt)

and coronary flow.

heart rates were noted.

No differences in

LDH released during reperfusion was

also significantly increased.

Similar changes in these

important indicators of cardiac function were also found by
Ledingham et al

(1990)

in their hypothermic cardioplegic

model with isolated rat hearts,

in which the same CPS as

used in this laboratory was employed to induce ischemia

(4

hours at 4°C).
After MI/R,

myocardial tissue lost 72.8% of it

preischemic ATP content

(postischemia 154 ± 16.2 vs

preischemia 546 ± 62 nmol/ g wet t i s s u e ) .

These data are in

agreement with the findings of other investigators who
employed long hy pothermic cardioplegia to induce MI/R damage
(Rousou et al 1986, Wyatt et al 1989).

The decline of ATP

content has been noted in almost every ischemic and

38
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reperfused model.

There is good correlation between

myocardial AT P level and left ventricular function
et al 1984,

Ledingham et al 1990,

(Flaherty

Ferrari et al 1985).

All

this evidence indicates that this normotherraic cardioplegiainduced model of M I / R injury is similar to that produced by
hypothermic cardioplegia in terms of changes in myocardial
functional and biochemical parameters.

However,

it is

superior to the others in terms of simplifying procedures
and shortening experimental time.
of levels of hypothermia

Additionally,

a variety

(4°C— 3 0°C) has been applied by

different authors and this variability makes comparisons
difficult.

It is well established that homogeneous

distribution of cooling during cardioplegia is difficult to
achieve in patients with coronary artery stenoses or
occlusions

(Menash et al 1988).

Under these situations,

the

myocardium is not entirely cooled during cold cardioplegia.
Warm cardioplegia is currently used in some medical
facilities for myocardial protection during open heart
procedures

(Lessana et al 1992).

clinical practices.

This model does mimic some

The protective effect of PFOB emulsions

indicates that this model may be used to evaluate the
efficacy of various treatments which might significantly
enhance the cardioprotection provided by cardioplegia.
The PFOB emulsions produced a dose-dependent protection
against MI / R injury as meas u re d by ventricular contractile
function.

Both 100% and 50% PFOB significantly increased

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

40

the extent of recovery of cardiac function while the effect
of 25% PFOB could not be distinguished from the control.
These results support the hypothesis that enhanced delivery
of oxygen to the heart during ischemic arrest can improve
m yocardial preservation.
AT P levels and DPs were not significantly decreased
after hearts were arrested with CPS containing 100% PFOB and
reperfused wit h KH.

Therefore,

the high correlation between

the preservation of cardiac function and maintenance of ATP
observed by others

(Godin et al 1989,

was verified in the current study.

Sellevold et al 1986)

There is good

experimental evidence that oxygenated PFC emulsions can
enhance the intramyocardial oxygen tension
Novick et al 1985).

(Rude et al 1982,

This maintains aerobic metabolism which

is otherwise lost during ischemia.

PFOB emulsion appeared

to be capable of m aintaining sufficient aerobic metabolism
to prevent ischemia-induced loss of ATP.

A large data base

supports the conclusion that other PFC emulsions can retard
high-energy phosphate decline during ischemia

(Rousou et al

1982, Flaherty et al 1984, Bando et al 1988).

When Rude et

al

(1982)

and Kanter et al

cardioplegia,

(1981)

compared PFC and blood

they proposed that the beneficial effects are

not only due to PFC emulsion's high oxygen transporting
ability,

but also due to the augmented myocardial O 2

consumption in the ischemic hearts receiving oxygenated PFC
emulsions

(i.e. the amount of oxygen which can be actually
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taken u p by the myocardium is h i g h ) .

This may occur as a

c onsequence of faster unloading rate of oxygen and
significant rheological features such as smaller particle
size and lower viscosity

(Fisher et al 1986).

Our study did

not address these possible mechanisms.
Carbon dioxide has about 2.5 times higher solubility
than oxygen in PFCs

(Geyer 1988).

relatively high pressure of C O 2
accounts for the tissue damage

During ischemia the

in the myocardium partially
(Rude et al 198 2).

PFOB

could absorb this byproduct of ischemia and therefore
diminish the tissue damage.
PFOB emulsions failed to significantly alter the
decrease in coronary flow that followed reperfusion.

This

evidence does not seem to correspond to the protection of
contractile function by highly concentrated emulsions.

It

has been reported previously that PFC emulsion-perfused
hearts had decreased coronary flow compared with those
receiving normal physiological solution
1985).

(Rahamathulla et al

The increased viscosity of PFC emulsions may account

for this event

(O'Neill et al 1981).

Menash et al

(1988)

indicated that applying a PFC emulsion during cardioplegia
diminished posti s ch em ic coronary flow even though
crystalloid ca rdioplegic solution did not exhibit decreased
coronary flow after reperfusion in their isolated rat heart
model.

The m e c h a n i s m of this phenomenon has not been

determined.

In our case,

one possibility would be that PFOB
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emulsions failed to modify the vascular damage caused by

MI/R.
GSH,

a cofactor of GPD, has a critical role in the

p rotection of myocardium against oxidative damage either by
inactivation of lipid peroxides or by eliminating hydrogen
peroxide.

The depletion of tissue GSH has been referred to

as a direct manifestation of myocardial oxidative injury
(Guarnieri et al 1980).

Thirty five minutes of cardioplegia

and reperfusion induced a reduction of the tissue GSH/GSSG
ratio.

This reduction results from a significant decline in

GSH w i t h GSSG unchanged.

This does not agree with other

reports and is difficult to interpret.

Increased oxidative

stress leads to the depletion of GSH, which should in turn
cause accumulation of GSSG in cell.

However,

marked release of LDH from the damaged tissue.

there was a
This implies

that the cell membrane was disrupted and GSSG may have been
lost from the cells into the coronary effluent upon
reperfusion.

Ferrari et al

(1985) have shown that

reperfusion of severely injured ischemic hearts causes a
marked and sustained release of GSH and GSSG as result of
peroxidation of cellular membranes.

The percentage of GSSG

release is higher than that of GSH,
PFOB retarded the loss of intracellular GSH that
normally occurs in MI/R.

This indicates that the

maintenance of oxygenation during cardioplegic arrest
prevents oxidative stress upon readministration of
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o xygen at ed physiological perfusate.

Formation of free

radicals is initiated during myocardial ischemic phase
et al 1983)

and GSH is depleted before reperfusion

et al 1988).

(Rao

(Ceconi

PFOB ma y also reduce the free radical

reactions caused by lower oxygen tension when the hearts
were ischemic.

However,

the present experiments have not

confirmed this mechanism.

Another contribution to this

event could be preservation of the cellular membrane.
Decreased lipid peroxidation in PFOB treated hearts could
help m a in t ai n the cellular membrane integrity and prevent
the leakage of GSH from the cell.

ATP plays a critical role

in membrane function and integrity

(Burton et al 1980,

Jennings et al 1978).

The high ATP level in PFOB treated

hearts ma y also contribute to this protection.
The activities of the antioxidant enzymes

(SOD, GPD,

C A T ) , which some investigators repeatedly demonstrated to be
lessened after MI/R injury

(Guarnieri et al 1980, Meerson ^

al 1982, Julicher et al 1984), were not affected by MI/R in
this model.

However,

there are numerous papers that present

unchanged values or even increased enzyme activity after the
damage
1987).

(Arduini et al 1988,

Godin et al 1989,

Shlafer et al

These discrepancies may relate to differences in the

duration of ischemia and reperfusion and the use of
different animal models.

In this case, the cardioplegic

solution applied during the ischemic episode may contribute
to the inability to detect any variation.

Although
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protective,

PFOB was not associated with any significant

effect on these enzymes and did not induce these enzymes in
the tissue.

This implies that the mechanism of the

protection by PFOB in this model may be due to its ability
to transport gases.
LDH release was not significantly diminished by the
100% PFOB although this concentration provided
cardioprotection in terms of mechanical and biochemical
parameters.
function.

LDH release did not correlate well with cardiac
This lack of correlation has been found in

previous studies in our laboratory and by other
investigators

(Grover and Sleph 1989,

In conclusion,

Irem et al 1991).

the results have shown that this

normothermic cardioplegia-induced MI/R injury model is
similar to the other MI / R models and can be used to study
the mechanisms and treatment of MI/R damage.

Enhanced

oxygen delivery during cardioplegia can diminish MI/R
injury.

The data suggest that PFOB enhances oxygen delivery

and might be used to reduce damage that occurs during
cardiac surgery and organ preservation.
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LACTATE DEHYDROGENASE ACTIVITY
Reagents:
Na pyruvate solution:
NADH solution

100 mg/L

(prepared immediately before u s e ) : lOO mg/ml

Color reagent:

200 m g / L of 2,4-Dinitrophenylhydrazine in
1 N HCl

NaOH solution:

0.4 N,

Instruments :
37°C water bath
Bausch & Lomb Spectronic 21
Procedure :
1).

1 ml of Na pyruvate solution and 10 ul of NADH solution
were pipetted into each of two labelled test tubes
(blank and s a m p l e ) , the tubes were placed in the 37°C
water bath for 5 minutes.

2).

0.5 ml of sample or blank

(Krebs-Henseleit solution)

were added and mi x e d gently.

Timer was started and the

tubes were kept in the 37°C water bath.
3).

After exactly 3 0 minutes of incubation,

the tubes were

removed from water bat h and 1 ml of color reagent was
added to each tube.

Tubes were mixed thoroughly and

allowed to remain at room temperature for 2 0 minutes.
4).

10 ml of NaOH solution wer e added to each tube and
mixed well.

5) . Between five and thirty minutes after adding the NaOH
solution,

absorbance was read and recorded with water
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as reference at a wavelength of 52 5 nm.
6

).

The LDH activity in the sample was expressed by as B-B
units/ml.

B-B units/ml =

(O.D.ga^pje - O-D.^iank)

x

1200 .

ADENOSINE TRIPHOSPHATE
Reagents;
Perchloric acid:

0.42 mM

KOH solution:

1 M

pH indicator:

0.1% chlorphenol red

Phosphate buffer:

215 m M K H 2 P O 4

and 2.3 -

8

mM

tetrabutylaraonium hydrogen sulphate
(TBAHS), pH 6.3
Mobile phase:

90% phosphate buffer:

10% acetonitrile

Instruments :
lEC B-20A Centrifuge
Milton Roy HPLC system
Procedure :
1) . Frozen tissue was quickly removed from

liquid nitrogen

and homogenized in perchloric acid solution

(10% W/V)

on ice.
2).

The homogenate was spun for 10 minutes
the chilled

(1 - 3 °C)

at 10,000 rpm in

centrifuge.

3) . The supernatant was transferred to a clean tube and KOH
solution was added to precipitate and neutralize
perchloric acid in the presence of the indicator.
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4).

The mixture was filtered through a microfilter and kept
on ice until 20 ul of sample was injected into the HPLC
system.

5).

The mobile phase was degassed before use.

The flow

rate was maintained at 0.7 ml/min and the
spectrophotometer was set at 2 59 nm.
6

).

Different ATP standard solutions were prepared with the
same procedure and used to establish the standard curve
for determination of the ATP in the tissue samples.

GLUTATHIONE

(GSH) AND GLUTATHIONE DISULFIDE

(GSSG)

Reagents :
5-Sulfosalicylic acid solution;
Stock buffer:

143 m M K H 2 P O 4

NADPH solution:

5%

and 6.3 m M EDTA,

pH 7.5

0.248 mg/ml in stock buffer. Stored at ice
cold and prepared daily

5,5'-Dithiobis(2-nitrobenzoic acid)

(DTNB):

6

mM DTNB was

prepared in the stock buffer and
stored frozen.

The stork buffer was

thawed before use and kept on ice .
GSSG reductase:

The stock enzyme was diluted to 266 U/ml
with stock buffer and stored

on ice during

the experiment.
GSH standards:

Standards were diluted daily in 5sulfosalicylic acid from a frozen

16

mM

stock solution which was prepared weekly in
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5-sulfosalicylic acid
2-Vinylpyridine
Triethanolamine
Instruments :
lEC B-2 0A Centrifuge
Bausch and Lomb Spectronic 600 with constant temperature
cuvette compartment
Procedure:
1).

Tissue samples were homogenized on ice with 5sulfosalicylic acid solution

(10% W/V).

The homogenate

was centrifuged for 10 minutes at 10,000 rpm in the
refrigerated
2).

(1-3°C)

centrifuge.

For the total amount of glutathione assay,

the

supernatant was ready to use in the following
procedure.

For GSSG measurement,

0.5 ml of supernatant

was mixed with 10 ul 2-vinylpyridine and 1 drop
(approximate 30 ul)

of triethanolamine

of the mixture was 6-7.

. The final pH

The mixture were allowed to

stay at room temperature for 60 minutes.
3).

700 ul of NADPH,

100 ul of DTNB and 175 ul of water

were pipetted into a cuvette.

The mixture was

prewarmed at 3 0°C for 10 minutes in the constant
temperature cuvette compartment of the spectrometer.
4).

25 ul of sample or standard solution was added.

5).

20 ul of glutathione reductase was added with mixing to
initiate the reaction.

Times were recorded when the
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absorbance was 0.5,
6

).

The reaction rate

1.0,

1.5, and 2.0 at 412 nm.

(AO.D./min) was estimated from the

slope of the regressed line in which absorbance
was plotted against time.

(O.D.)

The amount of GSH

equivalents was determined from a standard curve in
which the GSH equivalents present in the standard
solutions were plotted against the reaction rate.

GLUTATHIONE PEROXIDASE

(GPD) ACTIVITY

Reagents :
Phosphate buffer;
GSSG reductase:

0.1 M K H 2 P O 4 , 1 mM EDTA, pH 7.0

2.66 U/ml dilution in phosphate buffer
from the stock enzyme

GSH standard:

10 m M GSH in water

NADPH solution:
H 2 O2

solution:

1.5 m M NADPH in 0.1% NaHCOg
1.5 m M H 2 O 2

in water

Instruments :
IEC B-2 0A Centrifuge
Bausch and Lomb Spectronic 600 with a constant temperature
cuvette compartment
Procedure:
1).

Tissue samples were homogenized in phosphate buffer
W/V)

on ice and then spun for 10 minutes at

in the refrigerated
2).

500 ul of buffer,

(1-3°C)

(1 %

10,000 rpm

centrifuge.

100 ul of GSSG reductase,

100 ul of

GSH standard and 100 ul of sample or phosphate buffer
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as blank were pipetted into a cuvette.

The mixture was

preincubated at 37°C for 10 minutes in the constant
temperature cuvette compartment of the
spectrophotometer.
3).

100 ul of NADPH was added into the cuvette and mixed by
inversion.

The mixture was incubated for another 3

minutes.
4).

100 ul of H 2 O 2 was pipetted into the mixture and
quickly mixed to initiate the reaction.

The absorbance

at 365 nm was recorded for 5 minutes.
5).

The rate of change of absorbance

(AO.D./min) was

estimated from the slope of the regressed line in which
absorbance

(O.D.) was plotted against time.

The change

of absorbance was caused by the oxidation of NADPH in
the reaction mixture and therefore the rate of NADPH
oxidation

(mol NADP H oxidized/min)

was calculated from

the AO.D./min using the appropriate extinction
coefficient

(E=A/L*C).

The coefficient was measured by

reading the absorbance of NADPH standard solution with
the same cuvette and spectrophotometer.

The GPD

activity in samples was calculated from the difference
of the mol NADPH oxidized/min between the sample and
blank.
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SUPEROXIDE DISMUTASE

(SOD) ACTIVITY

Reagents:
Phosphate buffer:
Tris buffer:

10 itiM K 2 H P O 4

50 m M Tris

and 30 m M KCl pH 7.4

(buffer), 1 m M diethylenetriamine

pentacetic acid

(DTPA), pH 8.2

(The solution

is aerated by stirring vigorously at room
temperature for
Pyrogallol:

2 0

minutes before use)

24 m M in 10 m M HCl.

Instruments :
Branson Sonifier 450
lEC B-2 0A Centrifuge
Bausch & Lomb Spectronic 21
Procedure:
1).

The tissue sample was sonicated for 1 minute at an
output setting of 5 in ice-cold phosphate buffer.
homogenate was then centrifuged at
minutes in the refrigerated

1 0 , 0 0 0

The

rpm for

(l-3°c) centrifuge.

10

The

supernatant was us e d for determination of enzyme
activity
2).

.

3 ml of Tris buffe r w e r e added to 30 ul of supernatant
in a cuvette.

The reaction was initiated by adding

ul of p yrogallol solution.
absorbance at 420 nm,
oxidized pyrogallol,

2

5

The change of the

caused by the formation of the
was recorded for 2-3 minutes.

3).

A blank was run usi n g the Tris buffer plus pyrogallol.

4).

The autoxidation rate

(AO.D./min)

was estimated from
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the slope of the regressed line in which absorbance was
plotted against time.

The percentage of the

autoxidation rate inhibited by the enzyme sample was
calculated as:

%inhibation =

(AO.D.biank “

A O .D .s a m p l e ) / ♦ D •blank ^ 100%.

One unit of SOD

activity was defined as the amount which inhibits the
rate of autoxidation by 50%.

CATALASE

(CAT) ACTIVITY

Reagents:
Phosphate buffer No.l:
Ethanol solution:

10 mM K 2 H P O 4 , 3 0 mM KCl pH 7.4

10 % in the phosphate buffer No.l

Triton X-100 solution:

10% in phosphate buffer No.l

Phosphate buffer N o . 2: 5 mM KHgPO^,
H2 O2

solution:

5 mM K 2 H P O 4 , pH 7.0

m M in phosphate buffer N o . 2

6

H 2 SO 4

solution:

6

N in water

KMn 0 4

solution:

0.01 N in water

Instrument:
Branson Sonifier 450
lEC B-20A Centrifuge
Bausch & Lomb Spectro n i c 21
Procedure;
1) .

Tissue samples wer e sonicated for 1 minute at the
output setting at 5 in ice-cold phosphate buffer No.l.
The homogenate was then centrifuged at 10,000 rpm for
10 minutes in the refrigerated

(1-3°C)

centrifuge.
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2

).

0 . 1

ml of the supernatant was transferred to another

tube and 10 ul of ethanol solution was added.

The

mixture was kept on ice for 30 minutes.
3) .

10 ul of Triton X-100 solution was added into the
mixture.

4) .

The m i xture was diluted with 5 ml of phosphate buffer
No.l to prepare the final sample for assay.

5) .

5 ml of cold H 2 O 2

solution was added to each of two

reaction vials labelled sample and blank.

The reaction

was initiated by adding 0.5 ml of sample or blank
ml of phosphate
6

).

After

to the vials.

exactly 3 minutes,

rapidly adding
7).

buffer No.l)

1

(0.5

the reaction was stopped by

ml of H 2 SO 4

solution to each tube.

A spectrophotometric standard was preparedby adding 5.5
ml of p hosphate buffer No. 2, 1 ml of H 2 S O 4 solution and
7 ml of K M n 0 4

solution to the vial.

The readout of the

spectrophotometer was adjusted to read

absorbance

1 . 0

unit for the standard.
8

).

7 ml of K M n 0 4

reagent was added rapidly to each of the

remaining reaction mixtures from step
thoroughly,
9) .

(6 ) , mixed

and read at 480 nm within 3 0-60

seconds.

Since the decomposition of H 2 O 2 by catalase

followed

first-order kinetics,

the catalase activity was

expressed by the first-order reaction rate constant,
k = l o g ( S o / S 3 )x 2 .3 /t.
blank),

Here,

Sq = l-(the absorbance of

S 3 = l-(the absorbance of sample)

and t = 3 min.
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